In the last week, the Biotech industry is up 4.7%, with Innovent Biologics up 4.6%. In the past year, the industry is down 33%. As for the next few years, earnings are expected to grow by 36% per annum.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 09 May 2024 | HK$372.7b | HK$49.9b | -HK$19,255,795,412.73 | 12.1x | -19.4x | 7.5x |
Sat, 06 Apr 2024 | HK$331.0b | HK$49.3b | -HK$19,504,965,728.57 | 10.2x | -17x | 6.7x |
Mon, 04 Mar 2024 | HK$345.1b | HK$47.3b | -HK$20,408,369,433.16 | 15.9x | -16.9x | 7.3x |
Wed, 31 Jan 2024 | HK$313.0b | HK$47.3b | -HK$20,419,736,163.00 | 15.3x | -15.3x | 6.6x |
Fri, 29 Dec 2023 | HK$402.2b | HK$47.2b | -HK$20,416,752,846.00 | 17.4x | -19.7x | 8.5x |
Sun, 26 Nov 2023 | HK$414.2b | HK$46.3b | -HK$18,673,865,270.00 | 18.9x | -22.2x | 8.9x |
Tue, 24 Oct 2023 | HK$376.7b | HK$44.9b | -HK$19,082,550,269.00 | 12.7x | -19.7x | 8.4x |
Thu, 21 Sep 2023 | HK$420.8b | HK$45.0b | -HK$18,929,094,575.00 | 16.6x | -22.2x | 9.4x |
Sat, 19 Aug 2023 | HK$375.5b | HK$35.8b | -HK$22,913,212,275.00 | 17x | -16.4x | 10.5x |
Mon, 17 Jul 2023 | HK$413.6b | HK$35.6b | -HK$23,466,359,668.00 | 25.9x | -17.6x | 11.6x |
Wed, 14 Jun 2023 | HK$399.5b | HK$35.7b | -HK$23,492,514,256.00 | 25.2x | -17x | 11.2x |
Fri, 12 May 2023 | HK$443.4b | HK$36.6b | -HK$24,154,208,801.00 | 16.7x | -18.4x | 12.1x |
Sun, 09 Apr 2023 | HK$442.1b | HK$37.1b | -HK$24,186,857,438.00 | 12.2x | -18.3x | 11.9x |
Tue, 07 Mar 2023 | HK$413.6b | HK$33.2b | -HK$36,047,155,463.00 | 24.8x | -11.5x | 12.5x |
Thu, 02 Feb 2023 | HK$462.9b | HK$35.1b | -HK$35,514,478,382.00 | 31.3x | -13x | 13.2x |
Sat, 31 Dec 2022 | HK$410.8b | HK$34.2b | -HK$34,503,754,049.00 | 27.5x | -11.9x | 12x |
Mon, 28 Nov 2022 | HK$348.7b | HK$33.0b | -HK$33,145,211,467.00 | 20.8x | -10.5x | 10.6x |
Wed, 26 Oct 2022 | HK$320.0b | HK$33.5b | -HK$31,947,651,487.00 | 16.4x | -10x | 9.5x |
Fri, 23 Sep 2022 | HK$292.2b | HK$34.0b | -HK$33,254,537,479.00 | 20.6x | -8.8x | 8.6x |
Sun, 21 Aug 2022 | HK$325.5b | HK$33.5b | -HK$45,624,035,606.00 | 11.9x | -7.1x | 9.7x |
Tue, 19 Jul 2022 | HK$352.8b | HK$32.9b | -HK$46,276,984,332.00 | 13.5x | -7.6x | 10.7x |
Thu, 16 Jun 2022 | HK$339.1b | HK$32.9b | -HK$46,384,958,199.00 | 14.1x | -7.3x | 10.3x |
Sat, 14 May 2022 | HK$345.0b | HK$33.8b | -HK$45,403,282,702.00 | 13.1x | -7.6x | 10.2x |
Mon, 11 Apr 2022 | HK$358.7b | HK$36.4b | -HK$46,261,683,853.00 | 14.8x | -7.8x | 9.9x |
Wed, 09 Mar 2022 | HK$317.6b | HK$34.0b | -HK$31,245,923,017.00 | 12.3x | -10.2x | 9.3x |
Fri, 04 Feb 2022 | HK$301.6b | HK$31.1b | -HK$31,842,141,315.00 | 11.8x | -9.5x | 9.7x |
Sun, 02 Jan 2022 | HK$400.3b | HK$31.1b | -HK$31,899,069,449.00 | 12.9x | -12.5x | 12.9x |
Tue, 30 Nov 2021 | HK$505.9b | HK$31.0b | -HK$31,722,351,774.00 | 13.4x | -15.9x | 16.3x |
Thu, 28 Oct 2021 | HK$472.5b | HK$30.7b | -HK$31,791,126,750.00 | 14.6x | -14.9x | 15.4x |
Sat, 25 Sep 2021 | HK$513.3b | HK$30.5b | -HK$31,480,092,294.00 | 15.9x | -16.3x | 16.9x |
Mon, 23 Aug 2021 | HK$494.3b | HK$30.2b | -HK$32,058,827,347.35 | 14.8x | -15.4x | 16.4x |
Sat, 10 Jul 2021 | HK$651.9b | HK$30.2b | -HK$32,058,827,347.35 | 19.7x | -20.3x | 21.6x |
-23.6x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 1.66% | |
Healthcare | 2.48% | |
Biotech | 4.71% | |
Biotech | 4.71% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6990 Sichuan Kelun-Biotech Biopharmaceutical | HK$177.50 | 5.8% +HK$2.1b | n/a | PS23.3x | |
9926 Akeso | HK$50.50 | 3.5% +HK$1.5b | 15.2% | PE19.9x | |
9995 RemeGen | HK$32.30 | 7.7% +HK$1.2b | -19.8% | PS12.9x | |
2511 HighTide Therapeutics | HK$7.00 | 29.6% +HK$823.6m | n/a | PB4.7x | |
2162 Keymed Biosciences | HK$39.05 | 7.9% +HK$788.3m | -36.2% | PS28.2x |